New combo therapy shows promise for aggressive breast cancer
Disease control
Recruiting now
This study tests a new treatment called NECVAX-NEO1 for people with triple-negative breast cancer, a tough-to-treat type. It is given alongside standard chemotherapy and immunotherapy before and after surgery. The goal is to see if it is safe and helps control the disease better.…
Phase: PHASE1, PHASE2 • Sponsor: NEC Bio B.V • Aim: Disease control
Last updated May 26, 2026 07:44 UTC